For patients with stage T1a renal cell carcinoma (RCC), the use of thermal ablation has been increasing, while the use of radical nephrectomy has been declining.

Nephron-sparing surgery may not reduce the risk for later kidney failure in patients with kidney cancer and stage 4 CKD. Despite the promise of nephron-sparing, new study findings suggest that the ...

In patients with renal cell carcinoma, a phase 2 trial tested neoadjuvant stereotactic ablative radiation therapy to the inferior vena cava tumor thrombus before radical nephrectomy with thrombectomy.

Cardiac transplant status is not significantly associated with adverse in-hospital outcomes in patients with kidney cancer ...

Feb. 19, 2004 — Adjuvant treatment with autologous renal tumor cell vaccine seems to be beneficial in patients with organ-confined renal cell carcinoma, according to the results of a phase III, ...

Nephron-sparing management is one strategy to reduce risks, according to investigators. Older age is significantly associated with greater kidney function decline after radical nephrectomy in patients ...

NASHVILLE, Tenn. — A fully automated artificial intelligence approach predicted post-nephrectomy glomerular filtration rate with comparable accuracy as validated clinical prediction models, according ...

Minimally invasive techniques enable partial nephrectomies, preserving kidney function in most kidney cancer cases. Multidisciplinary care integrates surgery with targeted therapies and ...

Stage 2 kidney cancer involves a tumor over 7 cm, confined to the kidney, often treated surgically. Diagnosis includes imaging, blood tests, and possibly biopsy to confirm cancer type and stage.